Fischer Medical Ventures Names Dr. Iype Cherian Director to Lead Intraoperative MRI Innovation

 India 14th November,2025:- Fischer Medical Ventures Limited (FISCHER | 524743 | INE771F01041), a leading innovator in medical imaging and diagnostic solutions, has announced the appointment of Dr. Iype Cherian, globally renowned neurosurgeon, educator, and innovator, as Director of the company.

Dr. Cherian will play a key role in guiding the development of DRIS–iMRI Medharanya, a next-generation, AI-enabled, portable intraoperative MRI system designed to transform neurosurgical imaging and practice.

Under his leadership, Time Medical International Ventures (India) Pvt. Ltd., the wholly owned subsidiary of Fischer Medical Ventures Limited, aims to accelerate advancements in real-time intraoperative imaging and enhance surgical precision, safety, and outcomes.

‘With Dr. Cherian’s expertise and vision, Time Medical is entering an exciting new phase of innovation. The Interop MRI represents our commitment to developing cutting-edge, accessible solutions that bring world-class imaging into the surgical environment.” Said Ms. Svetlana, Director, Time Medical International Ventures (India) Pvt. Ltd.

Dr. Cherian is globally recognized for his pioneering work in neurosurgery, surgical education, and innovation. Currently serving as Director of Neuro Sciences at Parul Institute of Medical Sciences & Research, he is also the Founder and President of Neurosurgery Coach, a global platform for micro-neurosurgical training. His extensive experience and contributions to surgical technique and technology development make him a valuable addition to Fischer Medical’s leadership team.

“Glioma surgery is generally a blind surgery. Interoperative MRI gives vision to the surgeon — allowing them to see what has been taken and what is left. Small intraparenchymal lesions would be much easier to remove definitively if live imaging were available intraoperatively.” Said Dr. Iype Cherian, Neurosurgeon at Parul University.